Ending the HIV epidemic in the USA

Affiliations

¹ Department of Global Health, School of Public Health, Boston University, Boston, MA 02118, USA; Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: brooken@bu.edu.
² Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.

Comment

Brooke E Nichols et al. Lancet HIV. 2020 Jul.

. 2020 Jul;7(7):e454-e455.

doi: 10.1016/S2352-3018(20)30051-5. Epub 2020 Mar 5.

¹ Department of Global Health, School of Public Health, Boston University, Boston, MA 02118, USA; Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: brooken@bu.edu.
² Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.

No abstract available

Comment on

Ending the HIV epidemic in the USA: an economic modelling study in six cities.
Nosyk B, Zang X, Krebs E, Enns B, Min JE, Behrends CN, Del Rio C, Dombrowski JC, Feaster DJ, Golden M, Marshall BDL, Mehta SH, Metsch LR, Pandya A, Schackman BR, Shoptaw S, Strathdee SA; Localized HIV Modeling Study Group. Nosyk B, et al. Lancet HIV. 2020 Jul;7(7):e491-e503. doi: 10.1016/S2352-3018(20)30033-3. Epub 2020 Mar 5. Lancet HIV. 2020. PMID: 32145760 Free PMC article.